ARF5 Gene

ARF5 — ADP Ribosylation Factor 5

Overview

ADP Ribosylation Factor 5 (ARF5) is a member of the ARF family of small GTPases that play critical roles in intracellular membrane trafficking[@casler2024arftraffic]. As a key regulator of vesicle formation and transport between the Golgi apparatus and endoplasmic reticulum (ER), ARF5 is essential for maintaining cellular homeostasis. Emerging research suggests that dysregulation of ARF5-mediated trafficking pathways contributes to the pathogenesis of neurodegenerative diseases, particularly Alzheimer's disease (AD)[@chen2023adtraffic] and Parkinson's disease (PD)[@taylor2023asyntraffic]. This page provides a comprehensive overview of ARF5's molecular function, expression patterns, disease associations, and therapeutic implications.

ARF5 — ADP Ribosylation Factor 5

Overview

ADP Ribosylation Factor 5 (ARF5) is a member of the ARF family of small GTPases that play critical roles in intracellular membrane trafficking[@casler2024arftraffic]. As a key regulator of vesicle formation and transport between the Golgi apparatus and endoplasmic reticulum (ER), ARF5 is essential for maintaining cellular homeostasis. Emerging research suggests that dysregulation of ARF5-mediated trafficking pathways contributes to the pathogenesis of neurodegenerative diseases, particularly Alzheimer's disease (AD)[@chen2023adtraffic] and Parkinson's disease (PD)[@taylor2023asyntraffic]. This page provides a comprehensive overview of ARF5's molecular function, expression patterns, disease associations, and therapeutic implications.

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">ADP Ribosylation Factor 5</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>ARF5</td></tr>
<tr><td><strong>Full Name</strong></td><td>ADP Ribosylation Factor 5</td></tr>
<tr><td><strong>Chromosome</strong></td><td>7q31.2</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[381](https://www.ncbi.nlm.nih.gov/gene/381)</td></tr>
<tr><td><strong>OMIM</strong></td><td>103185</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000104081</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P26447](https://www.uniprot.org/uniprot/P26447)</td></tr>
<tr><td><strong>Protein Family</strong></td><td>ARF GTPase family</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>~20 kDa</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Alzheimer's Disease, Parkinson's Disease</td></tr>
</table>
</div>

Molecular Biology and Biochemistry

Structure and Classification

ARF5 belongs to the ARF family of small GTP-binding proteins, which are structurally related to heterotrimeric G protein alpha subunits[@dudley2005arf]. The ARF family comprises three classes: Class I (ARF1-3), Class II (ARF4-5), and Class III (ARF6), with ARF5 falling into Class II[@pasqualato2012arfstructure]. Like other ARF proteins, ARF5 functions as a molecular switch, cycling between an active GTP-bound state and an inactive GDP-bound state.

The protein consists of:

• N-terminal region: Contains a myristoylation site that facilitates membrane association
• GTP-binding domain (G-domain): Responsible for nucleotide binding and hydrolysis
• Switch I and Switch II regions: Conformational changes upon GTP/GDP binding that mediate interactions with effectors

GTPase Cycle and Regulation

ARF5 activity is tightly regulated by:

Cellular Functions

Membrane Trafficking

ARF5 plays a central role in regulating anterograde and retrograde transport between the Golgi apparatus and endoplasmic reticulum[@schindler2009arfgolgi]:

Lipid Metabolism

Beyond membrane trafficking, ARF5 influences lipid metabolism through activation of phosphatidylinositol 4-kinase (PI4K) and phospholipase D (PLD)[@jones2000arflipid]. These activities regulate phosphoinositide synthesis at the Golgi, phosphatidic acid production for membrane curvature, and lipid droplet dynamics.

Actin Cytoskeleton Dynamics

ARF5 modulates actin polymerization at the Golgi apparatus through interaction with cofilin and the Arp2/3 complex[@liu2015arfactin]. This regulation affects Golgi morphology and positioning, vesicle trafficking speed, and cell polarization and migration.

Expression Patterns

Tissue Distribution

ARF5 is ubiquitously expressed across human tissues, with highest expression in brain (particularly enriched in pyramidal neurons of the hippocampus and cortex), liver (high metabolic activity), and pancreas (insulin secretion involves intensive vesicle trafficking)[@morrow2020arfexpression].

Cellular Localization

In neurons, ARF5 localizes to the somatic Golgi apparatus, dendritic Golgi outposts, axon initial segment, and synaptic vesicle precursors.

Developmental Regulation

ARF5 expression increases during brain development, peaking in early adulthood and showing decreased expression in aging[@morrow2020arfexpression]. This pattern aligns with the known decline in synaptic plasticity and membrane trafficking efficiency during normal aging.

Role in Neurodegenerative Diseases

Alzheimer's Disease

Multiple mechanisms link ARF5 dysfunction to Alzheimer's disease pathogenesis[@chen2023adtraffic]:

Amyloid Precursor Protein (APP) Processing

ARF5-mediated trafficking influences APP trafficking through the secretory pathway. Proper trafficking ensures appropriate amyloid-beta (Aβ) generation and clearance. ARF5 regulates the subcellular localization of β-secretase (BACE1), affecting amyloidogenic APP processing. Altered ARF5 activity can increase Aβ production by accelerating APP transport through the Golgi.

Tau Pathology

ARF5 contributes to tau pathology through ER-Golgi trafficking of tau, autophagy-lysosome pathway impairment leading to accumulation of hyperphosphorylated tau, and exosome secretion modulation for tau spread[@mallucci2023tauseed].

Synaptic Dysfunction

In Alzheimer's disease, ARF5 dysfunction contributes to synaptic deficits through impaired synaptic vesicle recycling, dysregulated postsynaptic receptor trafficking, and disrupted dendritic spine maintenance.

Parkinson's Disease

ARF5 involvement in Parkinson's disease centers on:

Alpha-Synuclein Trafficking

ARF5 plays a role in the intracellular trafficking of alpha-synuclein[@taylor2023asyntraffic]. It regulates alpha-synuclein passage through the secretory pathway, impairs autophagic clearance of alpha-synuclein aggregates when dysfunctional, and modulates the release of toxic alpha-synuclein species via exosomes.

Mitochondrial Quality Control

ARF5 influences mitochondrial dynamics through regulating mitochondrial transport along axons and dendrites, contributing to mitophagy initiation, and modulating ER-mitochondria contact sites critical for mitochondrial calcium and lipid exchange.

Therapeutic Implications

Targeting ARF5 in AD

Several therapeutic strategies targeting ARF5-mediated pathways are under investigation:

Targeting ARF5 in PD

Therapeutic approaches for PD include enhancing autophagic flux through ARF5 modulation, targeting ARF5-mediated mitochondrial quality control, and restoring dopamine release through ARF5 pathway normalization.

Key Publications

See Also

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Alpha-Synuclein](/entities/alpha-synuclein)
• [Tau Protein](/entities/tau-protein)
• [Membrane Trafficking](/mechanisms/synaptic-vesicle-trafficking)
• [Autophagy in Neurodegeneration](/mechanisms/autophagy-neurodegeneration)
• [ER Stress and Neurodegeneration](/mechanisms/er-stress-unfolded-protein-response)
• [SNARE Proteins](/entities/snare-proteins)